Evidence map›Paper›PMID 38832801›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2024

Myrto Katsipoulaki, Mark H T Stappers, Dhara Malavia-Jones, Sascha Brunke, Bernhard Hube, Neil A R Gow

Abstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Microorganisms · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. bioRxiv : the preprint server for biology · 2026
    Article
  18. Article
  19. Article
  20. Treatment ofAJOG global reports · 2026
    Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Myrto KatsipoulakiDepartment of Microbial Pathogenicity Mechanisms, Hans Knoell Institute, Jena, Germany.ORCID 0009-0005-6322-6458
Mark H T StappersMRC Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom.ORCID 0000-0003-4154-7160
Dhara Malavia-JonesMRC Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom.ORCID 0000-0001-8981-7372
Sascha BrunkeDepartment of Microbial Pathogenicity Mechanisms, Hans Knoell Institute, Jena, Germany.ORCID 0000-0001-7740-4570
Bernhard HubeDepartment of Microbial Pathogenicity Mechanisms, Hans Knoell Institute, Jena, Germany.ORCID 0000-0002-6028-0425
Neil A R GowMRC Centre for Medical Mycology, University of Exeter, Exeter, United Kingdom.ORCID 0000-0002-2776-5850

Funding

Bundesministerium für Bildung und Forschung (BMBF) 13N15714Bundesministerium für Bildung und Forschung (BMBF) SAS-2015-HKI-LWCDeutsche Forschungsgemeinschaft (DFG) 467 390713860Deutsche Forschungsgemeinschaft (DFG) 528/20-1Medical Research Council Centre for Medical Mycology (MRC CMM) MR/N006364/2National Institute for Health and Care Research Exeter Biomedical Research CentreUKRI | Medical Research Council (MRC) MR/M026663/2University of ExeterWellcome TrustWellcome Trust 224323Wellcome Trust (WT) 101873, 200208, 215599
6 · The paper itself

Abstract

SUMMARYA significant increase in the incidence of

Indexed as

Antifungal AgentsCandida albicansCandida glabrataCandidiasisDrug Resistance, FungalAnimalsCandidemiaHost-Pathogen InteractionsHumansPhylogenyAntifungal Agentsantifungal resistanceCandida albicansCandida glabratacommensalismdiagnosticsepidemiologyhost responseNakaseomyces glabratuspathogenicityWHO fungal priority list

Identifiers

PMID38832801
PMCPMC11332356

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.